REG-Pharming announces CEO transition

Pharming announced that CEO and Executive Director Fabrice Chouraqui has stepped down with immediate effect after the board concluded their views on the company's strategic direction were not sufficiently aligned. The board appointed Chief Commercial Officer Leverne Marsh and CFO Kenneth Lynard as Interim Co-CEOs, splitting leadership between patient-focused operations and global corporate functions, and has begun a formal search for a permanent successor.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.